Evidence map›Paper›PMID 11821951›Full record

ArticleOncogene2002

Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer.

Ying Liu, Gracy Emilion, Andrew J Mungall, Ian Dunham, Stephan Beck, Valerie G Le Meuth-Metzinger, Andrew N Shelling, Francis M L Charnock, Trivadi S Ganesan

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  7. Review
  8. Chromosome 6 encoded RNaseT2 protein is a cell growth regulator.Journal of cellular and molecular medicine · 2010
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ying LiuICRF Molecular Oncology Laboratories, John Radcliffe Hospital, Headington, Oxford, OX3 9DS, UK.
Gracy Emilion
Andrew J Mungall
Ian Dunham
Stephan Beck
Valerie G Le Meuth-Metzinger
Andrew N Shelling
Francis M L Charnock
Trivadi S Ganesan

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have previously shown a high frequency of allele loss at D6S193 (62%) on chromosomal arm 6q27 in ovarian tumours and mapped the minimal region of allele loss between D6S297 and D6S264 (3 cM). We isolated and mapped a single non-chimaeric YAC (17IA12, 260-280 kb) containing D6S193 and D6S297. A further extended bacterial contig (between D6S264 and D6S149) has been established using PACs and BACs and a transcript map has been established. We have mapped six new markers to the YAC; three of them are ESTs (WI-15078, WI-8751, and TCP10). We have isolated three cDNA clones of EST WI-15078 and one clone contains a complete open reading frame. The sequence shows homology to a new member of the ribonuclease family. The other two clones are splice variants of this new gene. The gene is expressed ubiquitously in normal tissues. It is expressed in 4/8 ovarian cancer cell lines by Northern analysis. The gene encodes for a 40 kDa protein. Direct sequencing of the gene in all the eight ovarian cancer cell lines did not identify any mutations. Clonogenic assays were performed by transfecting the full-length gene in to ovarian cancer cell lines and no suppression of growth was observed.

Indexed as

Physical Chromosome MappingTranscription, GeneticAmino Acid SequenceAnimalsBase SequenceChromosomes, Human, Pair 6Colony-Forming Units AssayCOS CellsEpithelial CellsExonsExpressed Sequence TagsFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGenes, Tumor SuppressorGenetic MarkersGenetic MarkersRibonucleasesRNA, Messenger

Identifiers

PMID11821951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.